DERM
DERM
NASDAQ · Pharmaceuticals

Journey Medical Corp

$6.22
+0.30 (+5.07%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +151.8% upside
Low Target $10.95
Average Target $15.66
High Target $21.05
Current Price $6.22
Current
$6.22
Target
$15.66
$10.95 $15.66 avg $21.05
Scenario Analysis
Bear Case
$10.95
76.0%
Low target
Base Case
$15.66
+151.8%
Avg target
Bull Case
$21.05
+238.4%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$9.56
-34.9% from high
52-Week Low
$4.31
+44.3% from low
Target vs 52W High
$15.66
+63.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%